Blood Cancer Diagnostics Market

The Blood Cancer Diagnostics Market is segmented by Technology (Molecular/NGS, Flow Cytometry, Immunoassays, Cytogenetics, Others), Setting (Hospital Laboratories, Reference Laboratories, POCT/Near-patient Testing, Research & Academic Institutes), End User (Leukemia Diagnostics, Lymphoma Diagnostics, Myeloma Diagnostics, Other Haematological Malignancies), and Region. Forecast for 2026 to 2036.